Cyclosporine nephrotoxicity and the consequences of conversion to azathioprine.
D001379:Azathioprine / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003404:Creatinine / Q000097:blood; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D006084:Graft Rejection / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D016030:Kidney Transplantation; D007684:Kidney Tubules / Q000503:physiopathology; D011184:Postoperative Period; D011446:Prospective Studies; D011897:Random Allocation; D006435:Renal Dialysis
D003524:Cyclosporins; D003404:Creatinine; D001379:Azathioprine